| Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting (NCT03800875) | McGill University | 2019-02-08 |
| Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression (NCT03756129) | Novartis Pharmaceuticals | 2019-02-08 |
| Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection (NCT03788434) | Vedanta Biosciences, Inc. | 2019-02-08 |
| The Randomized OPTIMAL-ACT Trial (NCT03772613) | Mayo Clinic | 2019-02-08 |
| Urine Concentrations of Vilanterol After Inhaled Administration of Vilanterol/Fluticasone Furoate (NCT03739294) | Bispebjerg Hospital | 2019-02-08 |
| Ixazomib -Daratumumab Without Dexamethasone (IDara) in Elderly Relapse Refractory Multiple Myeloma (NCT03757221) | University Hospital, Caen | 2019-02-07 |
| Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD (NCT03824795) | MGB Biopharma Limited | 2019-02-07 |
| Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcinomas (NCT03722108) | UNICANCER | 2019-02-07 |
| A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation (NCT03513939) | Sernova Biotherapeutics Inc. | 2019-02-07 |
| Efficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination Genes (NCT03967938) | Universitair Ziekenhuis Brussel | 2019-02-07 |
| Inhaled Oxytocin and HPA Axis Reactivity (NCT03593473) | University of North Carolina, Chapel Hill | 2019-02-07 |
| A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune Hepatitis (NCT04129489) | Stero Biotechs Ltd. | 2019-02-07 |
| Post-Stroke Optimization of Walking Using Explosive Resistance (NCT03826771) | Medical University of South Carolina | 2019-02-06 |
| Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer (NCT03851445) | SWOG Cancer Research Network | 2019-02-06 |
| Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE) (NCT03831698) | University of Kansas Medical Center | 2019-02-06 |
| Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO (NCT02851472) | New York Medical College | 2019-02-06 |
| Evaluation of the Efficiacy of Mecobalamine in the Treatment of Long-term Pain in Women Diagnosed With Fibromyalgia (NCT05008042) | Linnaeus University | 2019-02-06 |
| Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants (NCT02620761) | Medical College of Wisconsin | 2019-02-06 |
| Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin. The ARIES Study (NCT03891238) | Consorzio Oncotech | 2019-02-06 |
| A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis (NCT03747575) | Genentech, Inc. | 2019-02-06 |
| Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer (NCT03581500) | M.D. Anderson Cancer Center | 2019-02-06 |
| CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer (NCT03568422) | Canadian Cancer Trials Group | 2019-02-05 |
| Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC (NCT03858972) | Odonate Therapeutics, Inc. | 2019-02-05 |
| A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults (NCT03824236) | GlaxoSmithKline | 2019-02-05 |
| A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's Disease (NCT03752970) | Boehringer Ingelheim | 2019-02-05 |
| Imiquimod for Preventing Keloid Recurrence (NCT03760250) | University of Pennsylvania | 2019-02-05 |
| PIPAC for the Treatment of Colorectal Peritoneal Metastases (NCT03868228) | Imperial College London | 2019-02-05 |
| TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets (NCT04362436) | Imperial College London | 2019-02-05 |
| Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo) (NCT03833466) | Peking University | 2019-02-05 |
| Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases (NCT03856658) | Corewell Health West | 2019-02-05 |
| Treatment of Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency (NCT03712930) | BeiGene | 2019-02-05 |
| Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia (NCT03519464) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-02-04 |
| Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas (NCT03598998) | City of Hope Medical Center | 2019-02-04 |
| Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder (NCT03529890) | Technical University of Munich | 2019-02-04 |
| Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning (NCT03852407) | University of Liege | 2019-02-04 |
| Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis (NCT03317392) | National Cancer Institute (NCI) | 2019-02-04 |
| AO-176 in Multiple Solid Tumor Malignancies (NCT03834948) | Arch Oncology | 2019-02-04 |
| Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis (NCT03824405) | Botanix Pharmaceuticals | 2019-02-04 |
| Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination (NCT04143412) | Beni-Suef University | 2019-02-04 |
| Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (NCT03482479) | University of Pennsylvania | 2019-02-04 |
| 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules (NCT03824535) | Andrei Iagaru | 2019-02-04 |
| Vagal Nerve Stimulation to Probe Inflammation and Brain in Post-traumatic Stress (NCT03858985) | VA Office of Research and Development | 2019-02-04 |
| Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery (NCT04177953) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2019-02-04 |
| Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin (NCT04852510) | Saudi German Hospital - Madinah | 2019-02-01 |
| Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia (NCT03823079) | Fudan University | 2019-02-01 |
| Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant (NCT03755310) | Diego García-Borreguero, MD, PhD | 2019-02-01 |
| Safety and Efficacy of Low-dose IL-2 in Birch Pollen Allergy (NCT03776643) | Assistance Publique - Hôpitaux de Paris | 2019-02-01 |
| Azithromycin Treatment for the Airway Microbiome in Asthma (NCT03736629) | University of Chicago | 2019-02-01 |
| Autologous Umbilical Cord Blood Treatment of Neonate With CHD (NCT03558269) | Sheba Medical Center | 2019-02-01 |
| A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase Ⅱa Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of Improve Other Aspects of Healthy Adult With Influenza Fever (NCT03830684) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-02-01 |
| Impact of Metformin on Immuno-virologic Parameters in HIV (NCT04500678) | University of Hawaii | 2019-02-01 |
| Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma (NCT03788174) | Fujian Cancer Hospital | 2019-02-01 |
| A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain (NCT03877718) | Charleston Laboratories, Inc | 2019-02-01 |
| Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds (NCT03732365) | Sonescence, Inc. | 2019-02-01 |
| Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis (NCT03829917) | Fundacion Nacional de Dermatologia | 2019-02-01 |
| Evaluation of the Effect of Incorporation of Vitamin C Into Platelet Rich Fibrin Scaffold in Treatment of Intra-osseous Periodontal Defects (NCT03707483) | Cairo University | 2019-02-01 |
| Efficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT (NCT05214066) | Chinese PLA General Hospital | 2019-02-01 |
| SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer (NCT03755115) | Henan Cancer Hospital | 2019-02-01 |
| Human Milk Fortification in Extremely Preterm Infants (NCT03797157) | Thomas Abrahamsson, MD, PhD | 2019-02-01 |
| A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus. (NCT03802617) | Kissei Pharmaceutical Co., Ltd. | 2019-02-01 |
| Effectiveness and Safety of Bushen Culuan Decoction for Anovulatory Infertility (NCT03709849) | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 2019-02-01 |
| Rituximab and Belimumab Combination Therapy in PR3 Vasculitis (NCT03967925) | Rachel Jones | 2019-02-01 |
| Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer (NCT03815461) | Chinese Academy of Medical Sciences | 2019-02-01 |
| Prevention of Delirium in Intensive Care by Melatonin (NCT03524937) | Assistance Publique - Hôpitaux de Paris | 2019-02-01 |
| Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC. (NCT03623776) | Sun Yat-sen University | 2019-02-01 |
| Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma (NCT03904927) | Fudan University | 2019-02-01 |
| UTOLA: UTerin OLAparib (NCT03745950) | ARCAGY/ GINECO GROUP | 2019-02-01 |
| Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors (NCT03874273) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2019-02-01 |
| The Efficacy of Probiotics to Reduce Antepartum Group B Streptococcus Colonization. (NCT03696953) | Marquette University | 2019-02-01 |
| A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients (NCT03602911) | West Virginia University | 2019-02-01 |
| Interim PET/CT-adapted Use of PD-1 Inhibitor Combined With De-escalated Chemotherapy-AVD in Classic Hodgkin Lymphoma (NCT07720011) | Peking University People's Hospital | 2019-02-01 |
| Tolperisone in Acute Muscle Spasm of the Back (NCT03802565) | Neurana Pharmaceuticals, Inc. | 2019-02-01 |
| Telmisartan Pilot Study on Treatment Resistant Schizophrenia (NCT03868839) | Xiaoduo Fan | 2019-02-01 |
| Phase 2 Dose Finding sPIF in Patients With High Panel Reactive Antibodies (NCT03593421) | Christopher O'Brien, MD | 2019-02-01 |
| MEBO Ointment and Hyaluronic Acid Gel in the Management of Pain After Free Gingival Graft Harvesting (NCT03728244) | Cairo University | 2019-02-01 |
| Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer (NCT04194125) | University of Warmia and Mazury | 2019-02-01 |
| Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection (NCT03468829) | Ablynx, a Sanofi company | 2019-02-01 |
| UCMSCs as Front-line Approach of Treatment for Patients With aGVHD (NCT03847844) | Cytopeutics Sdn. Bhd. | 2019-02-01 |
| Preoperative Paravertebral Block in Cancer Surgery of the Lung (NCT04209868) | Guy's and St Thomas' NHS Foundation Trust | 2019-02-01 |
| Prevention of Cardiac Dysfunction During Breast Cancer Therapy (NCT03760588) | Torbjorn Omland | 2019-01-31 |
| Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes (NCT03668470) | Hospices Civils de Lyon | 2019-01-31 |
| Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis (NCT03782792) | Boehringer Ingelheim | 2019-01-31 |
| Ropivacaine and Midazolam by Intraarticular vs Epidural Administration in Arthroscopic ACL (NCT05078372) | Universidad Autonoma de Nuevo Leon | 2019-01-31 |
| TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies (NCT03849651) | St. Jude Children's Research Hospital | 2019-01-31 |
| A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults (NCT03784079) | ViiV Healthcare | 2019-01-31 |
| Teduglutide for Enterocutaneous Fistula (ECF) (NCT02889393) | Daniel Dante Yeh | 2019-01-31 |
| Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism (NCT03773172) | Columbia University | 2019-01-31 |
| A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (NCT03535740) | Ariad Pharmaceuticals | 2019-01-31 |
| Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence (NCT03512249) | International AIDS Vaccine Initiative | 2019-01-31 |
| Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia (NCT03736564) | Mayo Clinic | 2019-01-31 |
| Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI (NCT03830905) | PHARMENTERPRISES LLC | 2019-01-31 |
| Seizure Prophylaxis in Patients With Glioma or Brain Metastasis (NCT03436433) | Duke University | 2019-01-31 |
| Needle-Knife Fistulotomy Vs. Standard Cannulation Trial (NCT06694038) | Thomas Jefferson University | 2019-01-31 |
| Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa (NCT03799627) | Akebia Therapeutics | 2019-01-31 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH) (NCT03812029) | Enyo Pharma | 2019-01-30 |
| Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations (NCT03212274) | National Cancer Institute (NCI) | 2019-01-30 |
| Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer (NCT04239443) | Hunan Cancer Hospital | 2019-01-30 |
| Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004) (NCT03776136) | Merck Sharp & Dohme LLC | 2019-01-30 |
| A Randomized Placebo-controlled Multicenter Trial to Evaluate the Efficacy and Safety of JTR-161, Allogeneic Human Dental Pulp Stem Cell, in Patients With Acute Ischemic stRoke (J-REPAIR) (NCT04608838) | Teijin Pharma Limited | 2019-01-30 |
| A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis (NCT03765788) | Novartis Pharmaceuticals | 2019-01-30 |